Product Images Spironolactone
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Spironolactone NDC 70518-0603 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Remedy_Label - Remedy Label
Spironolactone is a medication that comes in tablet form with 25mg per tablet. The package contains 30 tablets and is manufactured by Cadista Pharma. The medication should be kept out of children's reach and stored between the temperature ranges of 20-25°C and 15-30°C, as specified by USP. For usage directions, refer to the package insert. The medication was repackaged by RemedyRepack Inc. The lot number and expiration date are not available. RX ONLY.*
Spironolactone 25mg 70518 0603 01
Spironolactone is a prescription medication that is available in tablets containing 25 mg of the active ingredient. This package contains a quantity of 100 tablets and is RX Only. The NDC number for this medication is 70518-0602-01 and it was sourced from Cadista Pharma, Inc. in Salisbury, MD. The LOT # and expiration date are not available. The medication label advises keeping it and all medications out of reach of children and storing it at 20-25°C (58-77°F) with excursions permitted to 15-30°C (59-86°F). The directions for use are provided in the package insert. The medication was repackaged by RemedyRepack Inc. in Indiana, PA.*
Spironolactone 25mg 70518 0603 02
Spironolactone is a medication that is available by prescription only. The details mentioned on the label include its strength, manufacturing details, and expiry date. The medicine should be kept out of the reach of children and stored at a temperature between 20-25°C. The label directs the user to see the package insert for usage instructions. The medicine has been repackaged by RemedyRepack Inc. in Indiana, PA.*
Structure
fig01
This appears to be a comparison between two groups, one receiving Spironolactone and the other receiving a Placebo. The number 82 might indicate the sample size of the Spironolactone group. The value Logerankp is less than 0.001 suggesting a statistically significant difference between the two groups. The significance level of 0.001 is pretty significant, meaning that it is unlikely to be a result of chance. The term 'Months' could possibly signify the duration of the study.*
fig02
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
